Phase
Condition
Obesity
Diabetes Prevention
Circulation Disorders
Treatment
Sacubitril / Valsartan Oral Tablet [Entresto]
ACEI/ARB
Clinical Study ID
Ages 18-70 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Patients with essential hypertension
18-70 years old
No major barriers to provide written consent
Exclusion
Exclusion Criteria:
Secondary hypertension, except because of sleep apnea
cardiovascular disease (myocardial infarction, heart failure, stroke or coronaryrevascularization) within 6 months
Severe concomitant diseases (autoimmune disease, malignancy, late stage of liverdiseases, respiratory diseases and digestive diseases)
Unable to understand or comply with the study procedures
Study Design
Study Description
Connect with a study center
Beijing Friendship Hospital, Capital Medical University
Beijing, Beijing 100050
ChinaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.